Glode, A. E., & May, M. B. (2021). Immune checkpoint inhibitors: Significant advancements in non–small cell lung cancer treatment. American Journal of Health-System Pharmacy, 78(9), 769. https://doi.org/10.1093/ajhp/zxab041
Chicago Style (17th ed.) CitationGlode, Ashley E., and Megan B. May. "Immune Checkpoint Inhibitors: Significant Advancements in Non–small Cell Lung Cancer Treatment." American Journal of Health-System Pharmacy 78, no. 9 (2021): 769. https://doi.org/10.1093/ajhp/zxab041.
MLA (9th ed.) CitationGlode, Ashley E., and Megan B. May. "Immune Checkpoint Inhibitors: Significant Advancements in Non–small Cell Lung Cancer Treatment." American Journal of Health-System Pharmacy, vol. 78, no. 9, 2021, p. 769, https://doi.org/10.1093/ajhp/zxab041.